{{Rsnum
|rsid=10911902
|Chromosome=1
|position=186663185
|Orientation=plus
|GMAF=0.1203
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 61.1 | 35.4 | 3.5
| HCB | 73.7 | 25.5 | 0.7
| JPT | 63.7 | 34.5 | 1.8
| YRI | 100.0 | 0.0 | 0.0
| ASW | 86.0 | 14.0 | 0.0
| CHB | 73.7 | 25.5 | 0.7
| CHD | 73.4 | 24.8 | 1.8
| GIH | 69.3 | 25.7 | 5.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 77.6 | 22.4 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 75.5 | 22.5 | 2.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs10911902
|PubMedID=18347602
|Condition=Schizophrenia
|Gene=Intergenic
|Risk Allele=
|pValue=2.00E-006
|OR=1.79
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs10911902
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:18347602; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genomewide association for schizophrenia in the CATIE study: results of stage 1 (Initial Sample Size: 738 cases, 733 controls; Replication Sample Size: NR). This variant is associated with Schizophrenia.
|Drugs=
|Drug Classes=
|Diseases=Schizophrenia
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356463
}}

{{PMID Auto
|PMID=18768181
|Title=Association of polymorphisms in cyclooxygenase (COX)-2 with coronary and carotid calcium in the Diabetes Heart Study.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs10911902
|overall_frequency_n=14
|overall_frequency_d=128
|overall_frequency=0.109375
|n_genomes=9
|n_genomes_annotated=0
|n_haplomes=9
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}